search
Back to results

Impact of the Addition of a Device Providing Continuous Pneumatic Regulation of Tube Cuff Pressure to an Overall Strategy Aimed at Preventing Ventilator-associated Pneumonia in the Severe Trauma Patient. A Multicentre, Randomised, Controlled Study. (AGATE)

Primary Purpose

Ventilation-associated Pneumonia, Severe Trauma Patient

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
NOSTEN
Sponsored by
Poitiers University Hospital
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional prevention trial for Ventilation-associated Pneumonia focused on measuring Critical care, Trauma patients

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients having a severe trauma as defined by an Injury Severity Score (ISS) >15,
  • Aged at least 18 years,
  • Intubated for less than 15h,
  • Necessitating recourse to mechanical ventilation for an expected period ≥ 48h,
  • Participating in a social security scheme or benefiting from such a scheme by means of a third party.

Exclusion Criteria:

  • Patient likely to die over the 48h following admission,
  • Nasotracheal intubation,
  • Patient intubated through a tracheal tube with subglottic secretion drainage
  • Intubation carried out 24h or more after the trauma,
  • Ventilation with tracheotomy,
  • Refusal to participate in the research,
  • Contraindication to the head-up position,
  • Participation in another research protocol focusing on an anti-infective treatment or on a measure decreasing the risk of infection,
  • Persons benefiting from reinforced protection or persons deprived of freedom subsequent to a legal or administrative decision, minors under legal protection

Sites / Locations

  • Sigismond LASOCKI
  • Sébastien PILI FLOURY
  • Jean Michel CONSTANTIN
  • Catherine PAUGAM
  • Belaid BOUHEMAD
  • Dominique FALCON
  • Marc LEONE
  • Karim ASEHNOUNE
  • Carole ICHAI
  • Jean Yves LEFRANT
  • Olivier MIMOZ
  • Benoit VEBER
  • Julien POTTECHER

Outcomes

Primary Outcome Measures

Proportion of patients having developed VAP at D28 in intensive care according to the ATS definition

Secondary Outcome Measures

Proportion of patients having developed VAP in ICU according to the ATS definition
Proportion of patients having developed early (≤ day 7) or late (> day 7) VAP in ICU according to the ATS definition
Time to first episode of VAP diagnosis according to the ATS definition
Proportion of patients developing ventilator-associated events (VAE) according to the CDC definition
Number of ventilator free days
Number of antibiotic free days
ICU length-of-stay
Proportion of patient who died during their ICU stay
Proportion of patients requiring corticosteroids or bronchodilators within 48 hours of tracheal extubation

Full Information

First Posted
July 28, 2015
Last Updated
April 24, 2019
Sponsor
Poitiers University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02534974
Brief Title
Impact of the Addition of a Device Providing Continuous Pneumatic Regulation of Tube Cuff Pressure to an Overall Strategy Aimed at Preventing Ventilator-associated Pneumonia in the Severe Trauma Patient. A Multicentre, Randomised, Controlled Study.
Acronym
AGATE
Study Type
Interventional

2. Study Status

Record Verification Date
April 2018
Overall Recruitment Status
Completed
Study Start Date
July 31, 2015 (Actual)
Primary Completion Date
February 15, 2018 (Actual)
Study Completion Date
April 11, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Poitiers University Hospital

4. Oversight

5. Study Description

Brief Summary
Ventilation-associated pneumonia is the main site of healthcare-associated infections in the severe trauma patient, with a mean incidence rate of 35%. Ventilator-associated pneumonia increases morbi-mortality, length of stay in intensive care and overall management costs. As was recalled by the jury of the 2008 SFAR-SRLF consensus conference on the prevention of nosocomial infections contracted in intensive care, success in this preventive endeavour depends on a number of measures: orotracheal intubation route, maintaining tube cuff pressure between 25 and 30 cm H2O, maintaining a semi-seated position ≥30°, nasal and oropharyngeal care at regular intervals, striving to avoid unscheduled extubation, and use of a written sedation-analgesia algorithm allowing for early weaning from ventilation. Devices ensuring continuous pneumatic control of tube cuff pressure are more efficient in maintaining tracheal balloon pressure than intermittent adjustments using a hand-held manometer. In one study, these devices clearly facilitated diminution of microaspiration of gastric contents and of ventilator-associated pneumonia incidence density (9.7 vs. 22 VAP/1000 days of mechanical ventilation; p = 0.005). The investigators are putting forward the hypothesis that by adjoining a device providing continuous pneumatic regulation of tube cuff pressure to an overall strategy aimed at ventilator-associated pneumonia prevention (including semi-recumbent position ≥30°, oro-nasal-pharyngeal care at regular intervals and reduced risk exposure) can decrease VAP incidence by 50% in severely traumatised patients whose condition necessitates mechanical ventilation of an expected duration exceeding 48h. Ours is the first large-scale study to evaluate the interest of an innovative technology bundle on decrease of ventilator-associated pneumonia incidence in one of the intensive care populations the most at risk, namely severe trauma patients, a population presently benefiting from the other recommended preventive measures.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ventilation-associated Pneumonia, Severe Trauma Patient
Keywords
Critical care, Trauma patients

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Allocation
Randomized
Enrollment
440 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
NOSTEN
Other Intervention Name(s)
device providing continuous pneumatic regulation of tube cuff pressure
Primary Outcome Measure Information:
Title
Proportion of patients having developed VAP at D28 in intensive care according to the ATS definition
Time Frame
28 days
Secondary Outcome Measure Information:
Title
Proportion of patients having developed VAP in ICU according to the ATS definition
Time Frame
max 60 days
Title
Proportion of patients having developed early (≤ day 7) or late (> day 7) VAP in ICU according to the ATS definition
Time Frame
max 60 days
Title
Time to first episode of VAP diagnosis according to the ATS definition
Time Frame
max 60 days
Title
Proportion of patients developing ventilator-associated events (VAE) according to the CDC definition
Time Frame
max 60 days
Title
Number of ventilator free days
Time Frame
max 60 days
Title
Number of antibiotic free days
Time Frame
max 60 days
Title
ICU length-of-stay
Time Frame
max 60 days
Title
Proportion of patient who died during their ICU stay
Time Frame
max 60 days
Title
Proportion of patients requiring corticosteroids or bronchodilators within 48 hours of tracheal extubation
Time Frame
max 60 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients having a severe trauma as defined by an Injury Severity Score (ISS) >15, Aged at least 18 years, Intubated for less than 15h, Necessitating recourse to mechanical ventilation for an expected period ≥ 48h, Participating in a social security scheme or benefiting from such a scheme by means of a third party. Exclusion Criteria: Patient likely to die over the 48h following admission, Nasotracheal intubation, Patient intubated through a tracheal tube with subglottic secretion drainage Intubation carried out 24h or more after the trauma, Ventilation with tracheotomy, Refusal to participate in the research, Contraindication to the head-up position, Participation in another research protocol focusing on an anti-infective treatment or on a measure decreasing the risk of infection, Persons benefiting from reinforced protection or persons deprived of freedom subsequent to a legal or administrative decision, minors under legal protection
Facility Information:
Facility Name
Sigismond LASOCKI
City
Angers
ZIP/Postal Code
49100
Country
France
Facility Name
Sébastien PILI FLOURY
City
Besançon
ZIP/Postal Code
25030
Country
France
Facility Name
Jean Michel CONSTANTIN
City
Clermont-Ferrand
ZIP/Postal Code
63100
Country
France
Facility Name
Catherine PAUGAM
City
Clichy
ZIP/Postal Code
92110
Country
France
Facility Name
Belaid BOUHEMAD
City
Dijon
ZIP/Postal Code
21000
Country
France
Facility Name
Dominique FALCON
City
Grenoble
ZIP/Postal Code
38700
Country
France
Facility Name
Marc LEONE
City
Marseille
ZIP/Postal Code
13915
Country
France
Facility Name
Karim ASEHNOUNE
City
Nantes
ZIP/Postal Code
44000
Country
France
Facility Name
Carole ICHAI
City
Nice
ZIP/Postal Code
06000
Country
France
Facility Name
Jean Yves LEFRANT
City
Nîmes
ZIP/Postal Code
30900
Country
France
Facility Name
Olivier MIMOZ
City
Poitiers
ZIP/Postal Code
86021
Country
France
Facility Name
Benoit VEBER
City
Rouen
ZIP/Postal Code
76031
Country
France
Facility Name
Julien POTTECHER
City
Strasbourg
ZIP/Postal Code
67098
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
33727034
Citation
Marjanovic N, Boisson M, Asehnoune K, Foucrier A, Lasocki S, Ichai C, Leone M, Pottecher J, Lefrant JY, Falcon D, Veber B, Chabanne R, Drevet CM, Pili-Floury S, Dahyot-Fizelier C, Kerforne T, Seguin S, de Keizer J, Frasca D, Guenezan J, Mimoz O; AGATE Study Group. Continuous Pneumatic Regulation of Tracheal Cuff Pressure to Decrease Ventilator-associated Pneumonia in Trauma Patients Who Were Mechanically Ventilated: The AGATE Multicenter Randomized Controlled Study. Chest. 2021 Aug;160(2):499-508. doi: 10.1016/j.chest.2021.03.007. Epub 2021 Mar 13.
Results Reference
derived
PubMed Identifier
28790042
Citation
Marjanovic N, Frasca D, Asehnoune K, Paugam C, Lasocki S, Ichai C, Lefrant JY, Leone M, Dahyot-Fizelier C, Pottecher J, Falcon D, Veber B, Constantin JM, Seguin S, Guenezan J, Mimoz O; AGATE study group. Multicentre randomised controlled trial to investigate the usefulness of continuous pneumatic regulation of tracheal cuff pressure for reducing ventilator-associated pneumonia in mechanically ventilated severe trauma patients: the AGATE study protocol. BMJ Open. 2017 Aug 7;7(8):e017003. doi: 10.1136/bmjopen-2017-017003.
Results Reference
derived

Learn more about this trial

Impact of the Addition of a Device Providing Continuous Pneumatic Regulation of Tube Cuff Pressure to an Overall Strategy Aimed at Preventing Ventilator-associated Pneumonia in the Severe Trauma Patient. A Multicentre, Randomised, Controlled Study.

We'll reach out to this number within 24 hrs